Mitochondrial long chain fatty acid beta-oxidation in man and mouse.
暂无分享,去创建一个
R. Wanders | C. Hoppel | S. Houten | M. van Weeghel | J. Ruiter | H. Schulz | F. Wijburg | H. T. Brinke | M. S. Stoll | P. Minkler | M. Chegary | M. Stoll | H. Brinke
[1] D. Kurtz,et al. Structural characterization of the mouse long-chain acyl-CoA dehydrogenase gene and 5′ regulatory region , 1998, Mammalian Genome.
[2] C. Hoppel,et al. Quantification of carnitine and acylcarnitines in biological matrices by HPLC electrospray ionization-mass spectrometry. , 2008, Clinical chemistry.
[3] P. A. Wood,et al. Homozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouse. , 2005, Molecular genetics and metabolism.
[4] J. Vockley,et al. A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 Deficiency , 2007 .
[5] R. Wanders,et al. An improved enzyme assay for carnitine palmitoyl transferase I in fibroblasts using tandem mass spectrometry. , 2007, Molecular genetics and metabolism.
[6] J. Vockley,et al. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. , 2007, American journal of human genetics.
[7] J. Rottman,et al. Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. , 2006, American journal of physiology. Heart and circulatory physiology.
[8] Jerry Vockley,et al. Human Acyl-CoA Dehydrogenase-9 Plays a Novel Role in the Mitochondrial β-Oxidation of Unsaturated Fatty Acids* , 2005, Journal of Biological Chemistry.
[9] C. Hoppel,et al. Strategy for the isolation, derivatization, chromatographic separation, and detection of carnitine and acylcarnitines. , 2005, Analytical chemistry.
[10] N. Manning,et al. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts , 1990, Journal of Inherited Metabolic Disease.
[11] P. A. Wood,et al. Homozygous carnitine palmitoyltransferase 1a (liver isoform) deficiency is lethal in the mouse. , 2005, Molecular genetics and metabolism.
[12] J. Vockley,et al. Leaky beta-oxidation of a trans-fatty acid: incomplete beta-oxidation of elaidic acid is due to the accumulation of 5-trans-tetradecenoyl-CoA and its hydrolysis and conversion to 5-trans-tetradecenoylcarnitine in the matrix of rat mitochondria. , 2004, The Journal of biological chemistry.
[13] R. Wanders,et al. Changes in blood carnitine and acylcarnitine profiles of very long‐chain acyl‐CoA dehydrogenase‐deficient mice subjected to stress , 2004, European journal of clinical investigation.
[14] D. Rabier,et al. Recognition and management of fatty acid oxidation defects: A series of 107 patients , 1999, Journal of Inherited Metabolic Disease.
[15] F. A. Wijburg,et al. Disorders of mitochondrial fatty acyl-CoA β-oxidation , 1999, Journal of Inherited Metabolic Disease.
[16] G. Dacremont,et al. Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts , 1995, Journal of Inherited Metabolic Disease.
[17] J. Rottman,et al. Very-Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency in Mice , 2003, Circulation research.
[18] A. Moorman,et al. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.
[19] C. Roe,et al. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. , 2002, The Journal of clinical investigation.
[20] R. Wanders,et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. , 2002, Pediatrics.
[21] Piero Rinaldo,et al. Fatty acid oxidation disorders. , 2002, Annual review of physiology.
[22] C. Roe,et al. Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[23] D Matern,et al. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. , 2001, Human molecular genetics.
[24] J. Ibdah,et al. Lack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death. , 2001, The Journal of clinical investigation.
[25] J. Vockley,et al. Long-chain acyl-CoA dehydrogenase is a key enzyme in the mitochondrial beta-oxidation of unsaturated fatty acids. , 2000, Biochimica et biophysica acta.
[26] A. Mathur,et al. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. , 1999, Circulation.
[27] R. Wanders,et al. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[28] A H van Gennip,et al. Disorders of mitochondrial fatty acyl-CoA beta-oxidation. , 1999, Journal of inherited metabolic disease.
[29] D. Kurtz,et al. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Wanders,et al. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. , 1998, The Journal of clinical investigation.
[31] S. Denis,et al. 2,6-Dimethylheptanoyl-CoA is a specific substrate for long-chain acyl-CoA dehydrogenase (LCAD): evidence for a major role of LCAD in branched-chain fatty acid oxidation. , 1998, Biochimica et biophysica acta.
[32] P. Divry,et al. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[33] A. Strauss,et al. Regulation of the human long chain acyl-CoA dehydrogenase gene by nuclear hormone receptor transcription factors. , 1997, Biochimica et biophysica acta.
[34] H. Sprecher,et al. Peroxisomes Contain Δ3,5,Δ2,4-Dienoyl-CoA Isomerase and thus Possess All Enzymes Required for the β-Oxidation of Unsaturated Fatty Acids by a Novel Reductase-Dependent Pathway , 1995 .
[35] B. Poorthuis,et al. Identification and quantification of intermediates of unsaturated fatty acid metabolism in plasma of patients with fatty acid oxidation disorders. , 1995, Clinical chemistry.
[36] William,et al. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. , 1995, The Journal of clinical investigation.
[37] H. Sprecher,et al. Peroxisomes contain delta 3,5,delta 2,4-dienoyl-CoA isomerase and thus possess all enzymes required for the beta-oxidation of unsaturated fatty acids by a novel reductase-dependent pathway. , 1995, Biochemical and biophysical research communications.
[38] T. Hashimoto,et al. Identification of Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Three Patients Previously Diagnosed with Long-Chain Acyl-CoA Dehydrogenase Deficiency , 1993, Pediatric Research.
[39] T. Aoyama,et al. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. , 1993, Biochemical and biophysical research communications.
[40] D. Hale,et al. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. , 1990, Analytical biochemistry.
[41] J. Knudsen,et al. Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters. , 1990, The Biochemical journal.
[42] T Hashimoto,et al. Purification and properties of rat liver acyl-CoA dehydrogenases and electron transfer flavoprotein. , 1981, Journal of biochemistry.